glp-1 agonists drugs GLP-1s for Weight Loss: What You Need to Know

Cassandra Smith has rheumatoid arthritis and knows all too well how debilitating the autoimmune condition can be. That, coupled with over 300 pounds of weight, was a double negative against her health, Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 trial results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished It's estimated that about one in 10 Americans have taken a GLP1 weightloss drug, and demand is surging. A UNC Health weight loss patient shared her experience taking a GLP 1 medication with GLP 1 Alcohol Use Reduction: Can It Really Help? Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. GLP 1 agonists and neurovascular diseases Overnutrition has led to persistent health issues, such as obesity and metabolic syndrome in humans. Obesity is directly linked to chronic low grade inflammation, connecting our metabolic environment Who Qualifies for Semaglutide GLP 1 for Weight Loss?